HACEK ORGANISMS AND THEIR ROLE IN SUBACUTE INFECTIVE ENDOCARDITIS
Abstract
Infective Endocarditis is most commonly caused by gram-positive organisms; however, a small subset of cases is attributed to fastidious gram-negative bacteria known as the HACEK group (Haemophilus spp., Aggregatibacter spp., Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae). These organisms are part of the normal oropharyngeal flora and are characterized by slow growth and specific nutritional requirements, often leading to delayed or initially negative blood cultures. Although rare, HACEK organisms are clinically important causes of subacute infective endocarditis, typically affecting previously damaged heart valves or prosthetic valves. Patients often present with nonspecific symptoms such as prolonged fever, malaise, and new or changing heart murmurs, which can delay diagnosis. Advances in automated blood culture systems have improved detection rates, but prolonged incubation may still be required in some cases. Echocardiography remains essential for identifying valvular vegetations and confirming diagnosis. HACEK-associated endocarditis generally has a favorable prognosis when promptly treated with appropriate intravenous antibiotics, particularly third-generation cephalosporins. This review highlights the microbiological characteristics, clinical presentation, diagnostic challenges, and treatment strategies associated with HACEK group organisms as a rare but significant cause of infective endocarditis.
References
1. Baddour LM, Wilson WR, Bayer AS, et al.
Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. Circulation. 2015;132(15):1435–1486.
2. Holland TL, Baddour LM, Bayer AS, et al.
Infective endocarditis. Nature Reviews Disease Primers. 2016;2:16059.
3. Habib G, Lancellotti P, Antunes MJ, et al.
2015 ESC Guidelines for the management of infective endocarditis. European Heart Journal. 2015;36(44):3075–3128.
4. Murdoch DR, Corey GR, Hoen B, et al.
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the ICE-PCS study. Archives of Internal Medicine. 2009;169(5):463–473.
5. Fournier PE, Gouriet F, Casalta JP, et al.
Blood culture-negative endocarditis: improving the diagnostic yield using molecular methods. Clinical Infectious Diseases. 2017;65(4):635–642.
6. Das M, Badley AD, Cockerill FR.
Infective endocarditis caused by HACEK group organisms. Mayo Clinic Proceedings. 1997;72(1):59–64.
7. Chambers ST, Murdoch D, Morris A, et al.
HACEK infective endocarditis: characteristics and outcomes. Journal of Antimicrobial Chemotherapy. 2005;55(6):881–886.
8. Durack DT, Lukes AS, Bright DK.
New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. American Journal of Medicine. 1994;96(3):200–209.
9. Braunwald E.
Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Elsevier; 2019.
10. Murray PR, Rosenthal KS, Pfaller MA.
Medical Microbiology. 9th ed. Elsevier; 2020.




















